The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Effectiveness of pharmacist intervention for asthma control improvement
Open accessAbstract
Education on optimal medication use is an essential strategy to improve asthma control. The current authors investigated whether pharmacist interventions, focused on appropriate use of asthma medication and tailor-made to the patient's current asthma control, would improve asthma control in adult patients. A 6-month randomised, controlled, parallel-group trial was conducted in 66 community pharmacies in Belgium. Patients were randomly assigned to receive usual pharmacist care (n = 94) or a pre-defined pharmacist intervention (n = 107). This intervention mainly focused on improving inhalation technique and medication adherence. Primary outcome was the level of asthma control, as assessed by the Asthma Control Test® (ACT). Mean ACT scores did not change from baseline for both study groups. However, a pre-defined subgroup analysis of patients having insufficiently controlled asthma at baseline showed that the intervention had significantly increased the ACT score after 6 months compared with usual care. The intervention also reduced, for the complete study group, reliever medication use and the frequency of night-time awakenings due to asthma. Inhalation technique and adherence to controller medication were significantly better in the intervention group. In conclusion, pragmatic community pharmacy-based programmes can significantly improve therapeutic outcomes in adult asthma patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a subgroup analysis of patients having insufficiently controlled asthma at baseline showed the intervention group had significantly increased ACT scores after six months (mean ACT change from baseline in the intervention group was +2.3 and +0.3 in the control group (mean difference 2.0, 95% CI: 0.1, 3.9; p = 0.038).”
From Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice (2019) · cites this paper as [81]
In the citing paper
“The need for rescue medication was reduced in both groups from baseline, however a significantly higher reduction in the intervention group (-0.56 and -0.57 inhalations per day at three and six-month follow-up, respectively) was reported against control (-0.03 and -0.43 inhalations per day at three and six-month follow-up, respectively; p = 0.012)”
From Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice (2019) · cites this paper as [81]
In the citing paper
“Three RCTs reported on the level of asthma control and symptoms”
From Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice (2019) · cites this paper as [81]
In the citing paper
“Nine studies reported disease knowledge as an outcome [52, 66–68, 71, 81, 82, 88, 93, 111].”
From Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice (2019) · cites this paper as [81]
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,997
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Development of the asthma control test
Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., Murray, J. J., & Pendergraft, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.008 · Cited by 2,906
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
PAUWELS, R. A., Löfdahl, C., Postma, D. S., Tattersfield, A. E., O’Byrne, P. M., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,518
Schatz, M., Sorkness, C. A., Li, J. T., Marcus, P., Murray, J. J., Nathan, R. A., Kosinski, M., Pendergraft, T. B., & Jhingran, P. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.011 · Cited by 1,221
Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
Suissa, S., Ernst, P., Benayoun, S., Baltzan, M., & Cai, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430504 · Cited by 1,095
Rabe, K. F., Adachi, M., Lai, C. K. W., Soriano, J. B., Vermeire, P. A., Weiss, K. B., & Weiss, S. T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.042 · Cited by 940
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
(1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380222 · Cited by 860
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 778
Validation of a Standardized Version of the Asthma Quality of Life Questionnaire
Juniper, E. F., Buist, A. S., Cox, F. M., Ferrie, P. J., & King, D. (1999) · CHEST Journal · doi:10.1378/chest.115.5.1265 · Cited by 713
Compliance, Adherence, and Concordance
Horne, R. (2006) · CHEST Journal · doi:10.1378/chest.130.1_suppl.65s · Cited by 602
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
Giraud, V., & Roche, N. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00218402 · Cited by 538
Inhaled Steroids and the Risk of Hospitalization for Asthma
Donahue, J. G. (1997) · JAMA · doi:10.1001/jama.1997.03540350037030 · Cited by 510
Inhaled Corticosteroids for Asthma Therapy
Cochrane, M., BALA, M. M., Downs, K. E., Mauskopf, J., & Ben-Joseph, R. H. (2000) · CHEST Journal · doi:10.1378/chest.117.2.542 · Cited by 427
Newman, S. P., Weisz, A., Talaee, N., & Clarke, S. W. (1991) · Thorax · doi:10.1136/thx.46.10.712 · Cited by 323
Crompton, G. K., Barnes, P. J., Broeders, M. E. A. C., Corrigan, C. J., Corbetta, L., Dekhuijzen, R. P. N., Dubus, J. ‐., Magnan, A., Massone, F., Sanchis, J., et al. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.01.008 · Cited by 279
Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community
Armour, C. L., Bosnic-Anticevich, S. Z., Brillant, M., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L. D., & Stewart, K. (2007) · Thorax · doi:10.1136/thx.2006.064709 · Cited by 260
Boulet, L. (1998) · CHEST Journal · doi:10.1378/chest.113.3.587 · Cited by 240
Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease
Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., SESHADRI, R. M., Caffrey, H., Roesner, J. F., Smith, F. E., et al. (2002) · JAMA · doi:10.1001/jama.288.13.1594 · Cited by 214
Bonell, C. P., Oakley, A., Hargreaves, J., Strange, V., & Rees, R. W. (2006) · BMJ · doi:10.1136/bmj.333.7563.346 · Cited by 165
Cerveri, I., Locatelli, F., Zoia, M. C., Corsico, A. G., Accordini, S., de Marco, R., & Ecrhs, O. B. O. T. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b09.x · Cited by 158
Beunckens, C., Molenberghs, G., & Kenward, M. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn119oa · Cited by 153
Clinical consequences of inadequate inhalation technique in asthma therapy.
Lindgren, S., Bake, B., & Larsson, S. (1987) · PubMed · Cited by 141
Pharmaceutical Care Services for Asthma Patients: A Controlled Intervention Study
Schulz, M., Verheyen, F., Mühlig, S., Müller, J. M., Mühlbauer, K., Knop‐Schneickert, E., Petermann, F., & Bergmann, K. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010438 · Cited by 137
Barbanel, D. (2003) · Thorax · doi:10.1136/thorax.58.10.851 · Cited by 125 · cited 2×
“These studies have shown improvements in peak flow [12–15], asthma severity [10, 13], symptom scores [ 11 ], drug utilisation [10, 12–14] and humanistic”
BackgroundMethodEuropean barriers to the implementation of pharmaceutical care
van Mil, J. W. F., Boer, W. O., & Tromp, T. F. J. (2001) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2001.tb01044.x · Cited by 120
Influence of patients' characteristics and disease management on asthma control
Laforest, L., Ganse, E. H. V., Devouassoux, G., Bousquet, J., Chretin, S., Bauguil, G., Pachéco, Y., & Chamba, G. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.007 · Cited by 108
Development, Implementation, and Evaluation of a Community Pharmacy–Based Asthma Care Model
Saini, B., Krass, I., & Armour, C. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e045 · Cited by 106
Community Pharmacy–Based Pharmaceutical Care for Asthma Patients
Mangiapane, S., Schulz, M., Mühlig, S., Ihle, P., Schübert, I., & Waldmann, H.-C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g180 · Cited by 100
Predicted peak expiratory flow: Differences across formulae in the literature
Radeos, M. S., & Camargo, C. A. (2004) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2004.08.018 · Cited by 29
Mehuys, E., Bortel, L. M. V., Annemans, L., Remon, J. P., Tongelen, I. V., Ganse, E. H. V., Laforest, L., Chamba, G., & Brusselle, G. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.11.013 · Cited by 25
Self-citation
Research works printed but not linked: 4
- Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung and Blood Institute. Bethesda, National Institutes of Health, 2002; publication no. 02-3659
- 2001, Int J Pharm, 9, 163
- 1987, Eur J Respir Dis, 70, 93
- 1999, Eur Respir J, 14, 288
Cited by
Sorted by citations
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,023
Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,938
The prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R. L., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 815
Dineen-Griffin, S., Garcia-Cardenas, V., Williams, K., & Benrimoj, S. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220116 · Cited by 639
“measured the level of asthma control using the Asthma Control Test (ACT), a clinically validated measure [81].”
MethodAppropriateness of metered-dose inhaler use in the Yemeni community pharmacies
Al‐Worafi, Y. M. (2015) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2014.10.002 · Cited by 311
Metadata
- Authors
- Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J. P., & Brusselle, G.
- Affiliations
- Ghent University Hospital (BE)
- Corresponding author
- Mehuys, E.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-12-19
- Volume
- 31
- Issue
- 4
- Pages
- 790-799
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2159371369
- Cited by
- 218
- References
- 33
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 13 · 2022: 15 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 10 · 2017: 14 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 12 · 2012: 15
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- GlaxoSmithKline
- Universitair Ziekenhuis Gent
- Universiteit Gent
- Topics
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- asthma control, pharmacist intervention, community pharmacy, inhaler technique, medication adherence, controller medications, rescue medication, Asthma Control Test, adult asthma patients, patient education
- MeSH terms
- Administration, Inhalation, Adult, Asthma, Community Pharmacy Services, Female, Humans, Male, Middle Aged, Patient Compliance, Patient Education as Topic, Pharmacists, Self Administration, Severity of Illness Index, Anti-Asthmatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
